A detailed history of Larson Financial Group LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 1,806 shares of TXG stock, worth $26,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,806
Previous 1,322 36.61%
Holding current value
$26,909
Previous $25,000 60.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.71 - $23.49 $7,603 - $11,369
484 Added 36.61%
1,806 $40,000
Q2 2024

Aug 02, 2024

SELL
$19.45 - $37.37 $109,542 - $210,467
-5,632 Reduced 80.99%
1,322 $25,000
Q1 2024

May 03, 2024

SELL
$36.08 - $54.3 $65,918 - $99,206
-1,827 Reduced 20.81%
6,954 $260,000
Q4 2023

Feb 01, 2024

BUY
$34.32 - $57.55 $102 - $172
3 Added 0.03%
8,781 $491,000
Q3 2023

Nov 03, 2023

BUY
$40.86 - $62.98 $358,669 - $552,838
8,778 New
8,778 $362,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.42B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.